ArticleJournal, genetic engineering & biotechnology2026
Biocatalytic potential of Ensifer adhaerens S-5 D-Carbamoylase: Insights from in silico and in vitro analyses.
Article in Journal, genetic engineering & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green, environmentally friendly technologies are currently emerging in respect of pharmaceutical and biotechnological industries' development. D-carbamoylase is a valuable catalyst for the D-amino acids industry since it catalyzes the second step of "hydantoinase process", the key step in the production of food ingredients, drug precursors and drug intermediates. We conducted in silico and in vitro analyses to characterize D-carbamoylase from Ensifer adhaerens S-5, a synthetic gene that was cloned and expressed in Escherichia coli. The in silico study included generating a three-dimensional model of the enzyme using ColabFold, performing molecular docking to evaluate substrate binding affinities, and conducting 100 ns molecular dynamics (MD) simulations to observe the behavior of D-carbamoylase alone and in enzyme-ligand complexes. Overall, the MD simulations suggest thatthe enzyme alone and in complex with substrate remains stable during 100 ns simulation. Using molecular docking analysis, we examined substrates' affinityto the model and substrate-binding pocket interactions. Analysis showed that Val205 and Asp209 can form hydrogen bonds with N-carbamoyl-D-tryptophan. D-carbamoylase was overexpressed in Escherichia coli BL21 Star cells, with notable inclusion bodies formation. The inclusion bodies were treated with N-lauroylsarcosine to solubilize and refold the enzyme. Substrate specificity analysis revealed that the enzyme is active toward N-carbamoyl-D-tryptophan, N-carbamoyl-D-leucine, N-carbamoyl-D-valine, N-carbamoyl-D-phenylalanine, and N-carbamoyl-D-alanine. A parallel comparison was conducted between the studied Ensifer adhaerens carbamoylase and the enzyme previously characterized from Pseudomonas sp. strain KNK003A. The results encourage us to continue research and to explore the application of the enzyme in the "hydantoinase process" for production of D-amino acids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.